1. Balazsovits JAE, Mayer LD, Bally MB, Cullis PR, McDonnel M, Ginsberg RS, Falk RE (1989) Analysis of the effect of liposome encapsulation on the vesicant properties, cardiac toxicity, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol 23: 81?86
2. Batist G, Tulpule A, Sinha B, Katki AG, Myers CF, Cowan KH (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261: 15544?15559
3. Benjamin RS (1975) A practical approach to adriamycin (NSC-123127) toxicology. Cancer Chemother Rep 6: 191?198
4. Blum RH, Carter SK (1974) Adriamycin: a new anticancer drug with significant clinical activity. Ann Intern Med 80: 245?259
5. Gabizon A, Meshorer A, Barenholz Y (1986) Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst 77: 459?469